Direxion Daily PLTR Bear 1X Shares

UBS and Mizuho Upgrade Palantir Ratings, Suggesting Upside Potential

Akanda

Agape ATP

Co-Diagnostics

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NewGenIvf

Tradr 2X Long QBTS Daily ETF

Tradr 2X Long RGTI Daily ETF

Defiance Daily Target 2X Long RGTI ETF

LAFAYETTE ACQUISITION CORP ORD USD0.0001(S/R)24/10/2030

Netcapital

PLTR

PTIR

PLTW

PLOO

PLTU

PLTD

PLTG

Palantir reported a record Q1 revenue of $1.63B, up 85%, with U.S. sales increasing 104% and operating margins at 60%. However, concerns about high valuations persist, with a price-to-sales ratio of 66 and a forward P/E near 100. Analysts have mixed opinions, with price targets between $70 and $255 and consensus ratings of 'Moderate Buy' to 'Buy'.

- Q1 revenue rose 85% to $1.63 billion, with U.S. sales up 104% and operating margins at 60%.  
- Shares are trading at high multiples, including a price-to-sales ratio of approximately 66 and a forward P/E near 100, which raises concerns of overpricing.  
- Analyst price targets vary from $70 to $255, and consensus ratings are between 'Moderate Buy' and 'Buy', indicating uncertainty about future gains.

Palantir Tech

GraniteShares 2x Long PLTR Daily ETF

Roundhill PLTR WeeklyPay ETF

Defiance Leveraged Long +Income PLTR ETF

Leverage Shares 2x Cpd Acclrtd PLTRMnETF

Direxion Daily PLTR Bull 2X Shares

Leverage Shares 2X Long PLTR Daily ETF

Palantir's blowout quarter fails to lift high-priced stock

PLTZ

Top investor Danny Vena believes Palantir Technologies (NASDAQ:PLTR) is a buy due to its strong growth trajectory, with Q1 2026 showing 85% year-over-year revenue growth. Despite concerns over its premium valuation, Vena highlights a favorable PEG ratio of ~0.52, suggesting the stock is undervalued. Wall Street consensus rates PLTR as a Moderate Buy, with a 12-month price target indicating a potential 40% upside.

- Palantir Technologies is experiencing strong revenue and profit growth, with Q1 2026 showing 85% year-over-year sales growth of $1.63 billion.  
- Despite concerns over its valuation, investor Danny Vena suggests that the company's robust growth potential and a PEG ratio of around 0.52 indicate it is still a buy.  
- The consensus on Wall Street is a Moderate Buy, reflecting 13 Buys, 4 Holds, and 2 Sells, with a 12-month average price target suggesting a potential upside of nearly 40%.

Tip Ranks

Defiance Daily Target 2X Short PLTR ETF

'It's All About the Math,' Says Top Investor About Palantir Stock

HOOD

HOOG

GraniteShares has launched two new autocallable ETFs linked to Palantir and Robinhood, aiming to provide monthly income opportunities for investors. The GraniteShares Autocallable PLTR ETF and AHD ETF are designed to capitalize on the volatility of these popular retail stocks. Each fund has an expense ratio of 0.99% and targets periodic income through structured strategies, offering advantages like intraday liquidity and portfolio transparency.

- GraniteShares has launched two new autocallable income ETFs linked to Palantir Technologies Inc and Robinhood Markets Inc.  
- These funds, GraniteShares Autocallable PLTR ETF and GraniteShares Autocallable HOOD ETF, are part of the firm’s expanding suite targeting high-demand, income-generating strategies around volatile single stocks.  
- By incorporating autocallable strategies, these ETFs aim to provide periodic income while offering advantages like intraday liquidity and easier access through brokerage platforms.

benzinga_article

Robinhood

Leverage Shares 2X Long HOOD Daily ETF

NVIDIA

Tesla

Strategy

Coinbase

Invesco QQQ Trust

ServiceNow

Salesforce

NVIDIA Corporation

MicroStrategy Pref Shares MSTR 10.0 Perp

Microstrategy Inc Pref Shares STRC 9.0 Perp

MicroStrategy Pref Shares MSTR 8.0 Perp

Palantir, Robinhood Power GraniteShares' New Yield-Focused ETFs With Monthly Payouts

Palantir reported record U.S. growth with government revenue reaching $687 million in Q1 2026, an 84% increase year-over-year, prompting a full-year growth guidance boost to 71%. However, the company faces challenges in Europe as Germany's intelligence agency chose ChapsVision's ArgonOS, limiting its market presence. Analysts express a mixed outlook, noting potential as an AI operating system standard but cautioning against high valuations and dependence on government contracts.

- Palantir’s U.S. government revenue reached $687 million in Q1 2026, marking an 84% year-over-year increase, prompting management to raise full-year growth guidance to 71%.  
- The company faced a setback in Europe as Germany's intelligence agency chose ChapsVision over Palantir, citing data sovereignty issues.  
- While analysts recognize Palantir's potential to become a standard in AI operating systems, concerns about high valuation, slow international growth, and dependence on government contracts persist.

Palantir posts record growth but faces European market loss

Palantir remains a high-variance AI infrastructure bet where narrative and execution will matter equally over the next decade.

Where could Palantir be in 10 years? The bull and bear cases.

Palantir, a US technology firm, is facing criticism in the UK for its involvement in the NHS, with concerns over privacy and surveillance. Critics, including prominent figures and the British Medical Journal, argue that its data handling undermines NHS values. Despite this, Palantir claims to improve healthcare efficiency, with over 120 trusts using its platform. The debate centers on whether Palantir's technology is a solution to bureaucratic issues or a threat to civil liberties and trust in public institutions.

- Palantir, a US technology company, is facing criticism for its data handling and ties to military operations while also promising improvements to public services, particularly the NHS, where it has secured significant contracts.  
- Critics argue that its involvement undermines privacy and threatens the traditional patient-doctor relationship by centralizing health records, shifting control from GPs to the state.  
- Despite concerns, supporters highlight the efficiency gains from Palantir's technology, suggesting it could address longstanding bureaucratic challenges in the UK's health system.

The telegraph

Machiavellian spy firm or NHS saviour? The US giant love-bombing Britain

Palantir shares are down in 2026 after huge gains over the past three years.

NASDAQ Composite Index

This tech stock has outperformed the Nasdaq 3 years running, but is down 25% in 2026. Is now the time to buy?

CLOU

XDAT

Retail traders are trimming holdings of longtime AI favorite Palantir in a pivot from software stocks

businessinsider

Global X Cloud Computing ETF

Franklin Exponential Data ETF

ISHRS S&P Glb It

iShares US Digital Infrastructure and Real Estate ETF

SPDR S&P Software

Global X Data Center & Dgtl Infrs ETF

Proshares Big Data Refiners ETF

iShares Expanded Tech Software Sector ETF

Retail traders are trimming holdings of longtime AI favorite Palantir in a pivot from software stocks

Palantir's stock has fallen sharply this year despite strong Q1 earnings and raised guidance, as investors shift away from high-multiple AI stocks. Notably, insiders like Peter Thiel and Alex Karp have sold significant shares, with selling outpacing buying by over 9 to 1. Analysts are divided on the company's valuation, with price targets ranging from $90 to $255, indicating uncertainty about whether Palantir's growth justifies its high valuation multiples.

- Palantir's shares have declined despite strong Q1 results and increased guidance, as investors move away from high-multiple AI stocks.  
- Notably, executives Peter Thiel and Alex Karp have sold significant shares, with insider selling exceeding buying by over 9 to 1 recently.  
- Analysts are divided on the stock's outlook, with price targets varying widely from $90 to $255, indicating disagreement on the justification of its high valuation multiples.

Palantir insiders sell shares as valuation debate intensifies

Palantir's stock has seen a pullback following earnings, yet its strong revenue growth and increasing analyst targets indicate that the bullish outlook remains valid. Despite this, Palantir is not among the top stock recommendations from leading analysts, who suggest other stocks may be better investment options at this time.

- MarketBeat highlights that Palantir Technologies has a Moderate Buy rating from analysts.  
- However, it notes that top-rated analysts recommend five other stocks as better investment options before the market recognizes their potential.  
- Investors considering Palantir Technologies should be aware of these alternative recommendations.

Market Beat

Palantir's Critics Are "Right"—But They're Also Still Wrong

Direxion Daily PLTR Bear 1X Shares(PLTD.US)

Palantir's blowout quarter fails to lift high-priced stock

'It's All About the Math,' Says Top Investor About Palantir Stock

Palantir, Robinhood Power GraniteShares' New Yield-Focused ETFs With Monthly Payouts

Palantir posts record growth but faces European market loss

Where could Palantir be in 10 years? The bull and bear cases.

Machiavellian spy firm or NHS saviour? The US giant love-bombing Britain

This tech stock has outperformed the Nasdaq 3 years running, but is down 25% in 2026. Is now the time to buy?

Retail traders are trimming holdings of longtime AI favorite Palantir in a pivot from software stocks

Palantir insiders sell shares as valuation debate intensifies

Palantir's Critics Are "Right"—But They're Also Still Wrong